RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > Books: New Drug Approval Process, Fourth Edition, Accelerating Global Registrations

Books: New Drug Approval Process, Fourth Edition, Accelerating Global Registrations

Posted 01 April 2008 | By

One of my goals for 2007 was to find a text that would help me teach global regulatory affairs (regulatory requirements outside the US) as an instructor for the Regulatory Affairs Certificate program at the University of California, Santa Cruz extension. At first, I thought this was the text I sought. This book turned out to be a guidebook to drug development, like an abbreviated and condensed version of Bert Spilker's Guide to Clinical Trials. It does provide a global perspective on drug development and the registration process from preclinical to the filing of the New Drug Application (NDA) and all the bits and pieces that need to be taken into consideration, not just from a regulatory perspective.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.